Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ABOS	Acumen Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$121.33M	n/a	-172.3%	n/a	-$2.00
ABPO	Abpro Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$2.89M	n/a	n/a	n/a	-$1.30
ACOG	Alpha Cognition Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.22M	-$20.67M	-202.2%	-33.1%	n/a	-$1.18
ADMA	ADMA Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$510.17M	$146.93M	28.8%	30.8%	19.6%	$0.60
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
AGEN	Agenus Inc Manufacturing · Year ended 2025-12-31 · USD	$114.20M	-$3.08M	-2.7%	n/a	10.4%	$0.00
AGTX	Agentix Corp. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$485.6K	n/a	n/a	n/a	-$0.01
AIM	AIM ImmunoTech Inc. Manufacturing · Year ended 2025-12-31 · USD	$88.0K	-$13.96M	n/m	n/a	-48.2%	-$8.62
ALEC	Alector, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.05M	-$142.93M	-679.2%	-466.3%	-79.1%	-$1.39
ALGS	Aligos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.19M	-$24.19M	n/m	-45.2%	-39.5%	-$2.45
ALLO	Allogene Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$190.89M	n/a	-65.3%	-100.0%	-$0.87
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
APTN	Adaptin Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.17M	n/a	n/a	n/a	-$0.66
ARMP	Armata Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$173.80M	n/a	n/a	n/a	-$4.80
ARTV	Artiva Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$83.86M	n/a	-76.3%	-100.0%	-$3.43
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57
ATYR	aTYR PHARMA INC Manufacturing · Year ended 2025-12-31 · USD	$190.0K	-$74.12M	n/m	-109.8%	-19.1%	-$0.80
AURA	Aura Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$106.19M	n/a	-77.6%	n/a	-$1.76
AUTL	Autolus Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$75.39M	-$287.53M	-381.4%	-161.4%	644.9%	-$1.08
AVXL	Anavex Life Sciences Corp. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$46.38M	n/a	-48.9%	n/a	-$0.54
BCAB	BioAtla, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.61M	n/a	-164.7%	n/a	-$1.01
BCDA	BioCardia, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$8.23M	n/a	-919.3%	-100.0%	n/a
BCLI	Brainstorm Cell Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.31M	n/a	n/a	n/a	-$1.11
BCRX	BioCryst Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$874.84M	$263.86M	30.2%	n/a	94.1%	$1.21
BDTX	Black Diamond Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.00M	$22.37M	32.0%	19.9%	n/a	$0.39
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
BIIB	Biogen Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.89B	$1.29B	13.1%	7.1%	2.2%	$8.79
BKHA	Black Hawk Acquisition Corp Manufacturing · Year ended 2025-11-30 · USD	n/a	$1.33M	n/a	n/a	n/a	n/a
CABA	Cabaletta Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.86M	n/a	-149.8%	n/a	-$2.10
CADL	Candel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$38.18M	n/a	-73.5%	n/a	-$0.72
CCCC	C4 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.95M	-$104.99M	-292.1%	-40.9%	1.0%	-$1.27
CELZ	Creative Medical Technology Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.0K	-$6.00M	n/m	-79.8%	-45.5%	-$2.52
CERO	Cero Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.92M	n/a	n/a	n/a	n/a
CGEM	Cullinan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$219.88M	n/a	-53.8%	n/a	n/a
CGEN	Compugen Ltd Manufacturing · Year ended 2025-12-31 · USD	$72.76M	$35.34M	48.6%	34.4%	161.1%	$0.38
CGON	CG Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.04M	-$161.00M	n/m	-21.4%	254.7%	-$2.08
CGTX	Cognition Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.49M	n/a	-68.5%	n/a	-$0.32
CHRS	Coherus Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$168.02M	n/a	275.4%	n/a	$1.43
CLDI	Calidi Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.91M	n/a	-529.6%	n/a	-$5.95
CMPX	Compass Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$66.49M	n/a	-33.8%	-100.0%	n/a
CPMV	Mosaic ImmunoEngineering Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$687.8K	n/a	n/a	n/a	-$0.10
CRBU	Caribou Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.16M	-$148.12M	n/m	-121.2%	11.7%	-$1.59
CRDF	Cardiff Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$593.0K	-$45.85M	n/m	-101.0%	-13.2%	-$0.69
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58
CRSP	CRISPR Therapeutics AG Manufacturing · Year ended 2025-12-31 · USD	$3.51M	-$581.60M	n/m	-30.3%	-90.6%	-$6.47
CSBR	Champions Oncology, Inc. Manufacturing · Year ended 2026-04-30 · USD	$59.42M	-$1.18M	-2.0%	-29.8%	4.4%	-$0.08
CVM	CEL SCI Corp Manufacturing · Year ended 2025-09-30 · USD	n/a	-$25.41M	n/a	-159.2%	n/a	-$6.27
DBVT	DBV Technologies S.A. Manufacturing · Year ended 2025-12-31 · USD	$5.64M	-$146.95M	n/m	-87.1%	35.8%	-$1.05
DNA	Ginkgo Bioworks Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.16M	-$312.76M	-183.8%	-61.5%	-25.1%	-$5.64
DNLI	Denali Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$512.54M	n/a	-50.6%	n/a	-$2.97

Rows per page: 2550100